Apart from inhibiting EMT, an earlier study reported that pirfenidone inhibited TGF‐β and induced cell cycle arrest in NSCLC cells,35 suggesting its ability to inhibit tumor progression, invasion, and metastasis by inhibiting multiple TGF‐β‐associated pathways in NSCLC. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.